Unidad de Inmunopatología del SIDA, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcón, Madrid, Spain.
J Biol Chem. 2013 Mar 15;288(11):7626-7644. doi: 10.1074/jbc.M112.408294. Epub 2013 Jan 30.
HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-κB-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-κB-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.
HIV-1 的复制受到调节蛋白 Tat(101 个氨基酸)的有效控制,由两个外显子编码,尽管第一个外显子(1-72 个氨基酸)足以完成这一过程。Tat 可以被释放到细胞外基质中,作为一种可溶性促凋亡因子在邻近细胞中发挥作用。然而,HIV-1 感染的 CD4(+)T 淋巴细胞对凋亡表现出更高的抗性。我们观察到,Tat 的细胞内表达延迟了 FasL 介导的外周血淋巴细胞和 Jurkat 细胞凋亡,因为它是控制免疫激活期间 T 细胞动态平衡的必要途径。Jurkat-Tat 细胞显示出 caspase-8 激活受损、线粒体细胞色素 c 释放不足,以及 caspase-9 和 caspase-3 激活延迟。这种保护归因于对稳定线粒体膜完整性的蛋白质的深刻调控,如热休克蛋白、抑制素或核仁磷酸蛋白,以及 NF-κB 依赖性抗凋亡蛋白的上调,如 BCL2、c-FLIPS、XIAP 和 C-IAP2。这些效应在表达全长 Tat(Jurkat-Tat101)的 Jurkat 细胞中观察到,但在表达 Tat 第一外显子的 Jurkat 细胞(Jurkat-Tat72)中观察不到,证明第二个外显子,特别是与 NF-κB 相关的 ESKKKVE 基序,是 Tat 介导的 FasL 凋亡保护所必需的。因此,Tat 发挥的保护作用与其作为病毒转录和延伸的调节剂的功能无关。此外,这些数据证明 HIV-1 可能已经开发出通过表达 Tat 来延迟感染的 CD4(+)T 淋巴细胞中 FasL 介导的凋亡的策略,从而有利于 HIV-1 在感染的 T 细胞中持续复制。